0000000000617922

AUTHOR

Stefan Wieczorek

showing 2 related works from this author

TNFA promoter polymorphisms and narcolepsy

2003

Narcolepsy is a debilitating sleep disorder that affects up to 0.05% of individuals in Caucasian populations. It is highly associated with the HLA-DR2 group antigen or the HLA-DRB1*1501-DQB1*0602 haplotype, respectively. However, the HLA association by itself cannot sufficiently explain the increased risk to family members, as HLA-DR2 is quite common in the general population and most people harboring the respective genotype do not develop any symptoms of narcolepsy. Situated in the HLA class II region, the TNFA gene is translated into the pro-inflammatory cytokine TNF-alpha. TNFA promoter polymorphisms have been linked to several inflammatory and autoimmune diseases. We analyzed three SNP …

ImmunologyPopulationHuman leukocyte antigenBiochemistryPolymorphism Single NucleotideGene FrequencyGenotypeGeneticsmedicineImmunology and AllergySNPHumanseducationPromoter Regions GeneticAllelesGenetic associationNarcolepsyGeneticseducation.field_of_studyPolymorphism GeneticGenetic heterogeneitybusiness.industryTumor Necrosis Factor-alphaHaplotypeGeneral MedicineHLA-DR Antigensmedicine.diseaseImmunologybusinessNarcolepsyMicrosatellite Repeats
researchProduct

Increased Frequency of Migraine in Narcoleptic Patients: A Confirmatory Study

2003

Previously we have reported an increased prevalence of migraine in narcoleptic patients. Because of the theoretical and clinical implications of this finding we recruited an independent new study sample of 100 patients with proven narcolepsy and conducted a structured 26-item interview based on the international diagnostic criteria for headache disorders, the Kiel Headache Questionnaire. Narcolepsy symptoms were measured by means of the Stanford Centre for Narcolepsy Sleep Inventory. Migraine prevalence was twofold to fourfold increased in the narcoleptic patients and amounted to 44.4% in women and 28.3% in men. The onset of narcolepsy symptoms was 12.3 ± 11.4 years before the onset of mig…

Pediatricsmedicine.medical_specialtyCataplexyCross-sectional studybusiness.industryGeneral Medicinemedicine.diseaseComorbidityMigrainemedicineNeurology (clinical)Headache DisordersAge of onsetmedicine.symptomPsychiatrybusinessBody mass indexNarcolepsyCephalalgia
researchProduct